Out-of-specification (OOS) results were found for atomoxetine content (below the lower limit) and, for one batch, failure in capsule mass uniformity, which may lead to administration of too low a dose of the active substance. Potential effects: reduced treatment efficacy, possible worsening of disease symptoms.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use the specified batches of Konaten, check the batch number on the packaging, return the product to the pharmacy, and if needed consult a doctor to ensure continuity of treatment with an alter...
All listed batches of Konaten were withdrawn from the market throughout the country, their placing on the market was prohibited, and the decision was given immediate enforceability; previously, the di...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related